Identifying Subclinical Transthyretin Cardiac Amyloidosis in V142I TTR Carriers: Design, Rationale, and Methods of the VISTA (Variant Imaging of Subclinical Transthyretin Amyloidosis) Study

Key Points

• Subclinical cardiac amyloidosis was identified in V142I TTR carriers, indicating the need for earlier diagnosis strategies.
• The study examines imaging techniques to detect transthyretin amyloidosis with a focus on V142I variant carriers.
• Assessment utilizes advanced imaging methods to highlight biomarkers indicative of cardiac amyloidosis.
• Findings underscore the importance of early intervention, although further validation in larger populations is necessary.